LLY
Eli Lilly and Company
NYSE: LLY · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$934.60
+9.80% today
Updated 2026-04-30
Market cap
$760.43B
P/E ratio
37.03
P/S ratio
11.67x
EPS (TTM)
$22.99
Dividend yield
0.69%
52W range
$620 – $1,132
Volume
3.0M
Eli Lilly and Company (LLY) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $21.96B | $26.79B | $29.21B | $27.46B | $31.00B | $33.66B | $34.40B | $35.25B | $36.31B | $35.57B | $38.81B | $44.98B | $43.91B | $39.29B | $46.63B | $48.81B | $49.49B | $64.01B | $78.71B | $112.48B |
| Cash & equivalents | $3.11B | $3.22B | $5.50B | $4.46B | $5.99B | $5.92B | $4.02B | $3.83B | $3.87B | $3.67B | $4.58B | $6.54B | $7.32B | $2.34B | $3.66B | $3.82B | $2.07B | $2.82B | $3.27B | $7.16B |
| Current assets | $9.69B | $12.32B | $12.45B | $12.49B | $14.84B | $14.25B | $13.04B | $13.10B | $11.93B | $12.57B | $15.10B | $19.20B | $20.55B | $13.71B | $17.46B | $18.45B | $18.03B | $25.73B | $32.74B | $55.63B |
| Total liabilities | $10.97B | $13.37B | $22.48B | $17.94B | $18.59B | $20.12B | $19.63B | $17.61B | $20.92B | $20.98B | $24.73B | $33.31B | $33.00B | $36.59B | $40.81B | $39.65B | $38.71B | $53.14B | $64.44B | $85.94B |
| Current liabilities | $5.09B | $5.27B | $13.11B | $6.57B | $7.10B | $8.93B | $8.39B | $8.92B | $11.21B | $8.23B | $10.99B | $14.54B | $11.89B | $11.78B | $12.48B | $15.05B | $17.14B | $27.29B | $28.38B | $35.23B |
| Long-term debt | $3.49B | $4.59B | $4.62B | $6.63B | $6.77B | $5.46B | $5.52B | $4.20B | $5.37B | $7.97B | $8.37B | $9.94B | $11.64B | $13.82B | $16.59B | $15.35B | $14.74B | $18.32B | $28.53B | $40.87B |
| Shareholder equity | $10.98B | $13.42B | $6.74B | $9.53B | $12.41B | $13.54B | $14.77B | $17.64B | $15.39B | $14.59B | $14.08B | $11.67B | $10.91B | $2.70B | $5.83B | $9.15B | $10.65B | $10.77B | $14.19B | $26.54B |
| Retained earnings | $10.93B | $11.81B | $7.65B | $9.83B | $12.73B | $14.90B | $16.09B | $16.99B | $16.48B | $16.01B | $16.05B | $13.89B | $11.40B | $4.92B | $7.83B | $8.96B | $10.04B | $10.31B | $13.54B | $24.47B |
| Accounts receivable | $2.69B | $3.70B | $3.28B | $3.83B | $4.16B | $4.24B | $3.89B | $4.02B | $3.80B | $4.07B | $4.77B | $5.26B | $5.78B | $5.54B | $6.93B | $8.13B | $8.56B | $11.34B | $13.28B | $20.16B |
| Inventory | $2.27B | $2.52B | $2.49B | $2.85B | $2.52B | $2.30B | $2.64B | $2.93B | $2.74B | $3.45B | $3.56B | $4.46B | $3.10B | $3.19B | $3.98B | $3.89B | $4.31B | $5.77B | $7.59B | $13.74B |
| Goodwill | — | $745.70M | $1.17B | $1.18B | $1.42B | $1.43B | $1.50B | $1.52B | $1.76B | $4.04B | $3.97B | $4.37B | $1.37B | $3.68B | $3.77B | $3.89B | $4.07B | $4.94B | $5.77B | $5.90B |